{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:14:54Z","timestamp":1792782894831,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007664","name":"Manpei Suzuki Diabetes Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CA1940\/1-1"],"award-info":[{"award-number":["CA1940\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013143","name":"Manton Center for Orphan Disease Research, Boston Children's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013143","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006823","name":"Boston Children's Hospital","doi-asserted-by":"publisher","award":["Ophthalmology Foundation"],"award-info":[{"award-number":["Ophthalmology Foundation"]}],"id":[{"id":"10.13039\/100006823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006823","name":"Boston Children's Hospital","doi-asserted-by":"publisher","award":["OFD\/BTREC\/CTREC Faculty Career Development Grant"],"award-info":[{"award-number":["OFD\/BTREC\/CTREC Faculty Career Development Grant"]}],"id":[{"id":"10.13039\/100006823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006823","name":"Boston Children's Hospital","doi-asserted-by":"publisher","award":["Ophthalmology Foundation"],"award-info":[{"award-number":["Ophthalmology Foundation"]}],"id":[{"id":"10.13039\/100006823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006823","name":"Boston Children's Hospital","doi-asserted-by":"publisher","award":["The Vascular Biology Program and the Boston Children\u2019s Hospital Surgery Foundation"],"award-info":[{"award-number":["The Vascular Biology Program and the Boston Children\u2019s Hospital Surgery Foundation"]}],"id":[{"id":"10.13039\/100006823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006823","name":"Boston Children's Hospital","doi-asserted-by":"publisher","award":["1U54HD090255 (IDDRC)"],"award-info":[{"award-number":["1U54HD090255 (IDDRC)"]}],"id":[{"id":"10.13039\/100006823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY030140"],"award-info":[{"award-number":["R01EY030140"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY029238"],"award-info":[{"award-number":["R01EY029238"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009693","name":"Little Giraffe Foundation","doi-asserted-by":"publisher","award":["Foundation"],"award-info":[{"award-number":["Foundation"]}],"id":[{"id":"10.13039\/100009693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Wallenberg Clinical Scholars"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R24EY024868"],"award-info":[{"award-number":["R24EY024868"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY017017"],"award-info":[{"award-number":["EY017017"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY01717-13S1"],"award-info":[{"award-number":["R01EY01717-13S1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY030904-01"],"award-info":[{"award-number":["EY030904-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mass Lions Eye Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s10456-020-09717-x","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T11:03:56Z","timestamp":1583406236000},"page":"385-394","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Free fatty acid receptor 4 activation protects against choroidal neovascularization in mice"],"prefix":"10.1007","volume":"23","author":[{"given":"Yohei","family":"Tomita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertan","family":"Cakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Hsiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjie","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve S.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Britton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Puder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Hellstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saswata","family":"Talukdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1013-5737","authenticated-orcid":false,"given":"Lois E. H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"issue":"4","key":"9717_CR1","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/archopht.122.4.564","volume":"122","author":"DS Friedman","year":"2004","unstructured":"Friedman DS, Ocolmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, Nemesure B, Mitchell P, Kempen J, Eye Diseases Prevalence Research G (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122(4):564\u2013572. https:\/\/doi.org\/10.1001\/archopht.122.4.564","journal-title":"Arch Ophthalmol"},{"issue":"14","key":"9717_CR2","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1056\/NEJMra062326","volume":"355","author":"PT de Jong","year":"2006","unstructured":"de Jong PT (2006) Age-related macular degeneration. N Engl J Med 355(14):1474\u20131485. https:\/\/doi.org\/10.1056\/NEJMra062326","journal-title":"N Engl J Med"},{"issue":"10","key":"9717_CR3","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1097\/IAE.0b013e3181884fd2","volume":"28","author":"DR Fintak","year":"2008","unstructured":"Fintak DR, Shah GK, Blinder KJ, Regillo CD, Pollack J, Heier JS, Hollands H, Sharma S (2008) Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina 28(10):1395\u20131399. https:\/\/doi.org\/10.1097\/IAE.0b013e3181884fd2","journal-title":"Retina"},{"issue":"12","key":"9717_CR4","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1016\/j.ophtha.2013.05.018","volume":"120","author":"A Rasmussen","year":"2013","unstructured":"Rasmussen A, Bloch SB, Fuchs J, Hansen LH, Larsen M, LaCour M, Lund-Andersen H, Sander B (2013) A 4-year longitudinal study of 555 patients treated with ranibizumab for neovascular age-related macular degeneration. Ophthalmology 120(12):2630\u20132636. https:\/\/doi.org\/10.1016\/j.ophtha.2013.05.018","journal-title":"Ophthalmology"},{"issue":"1","key":"9717_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ophtha.2013.08.015","volume":"121","author":"JE Grunwald","year":"2014","unstructured":"Grunwald JE, Daniel E, Huang J, Ying GS, Maguire MG, Toth CA, Jaffe GJ, Fine SL, Blodi B, Klein ML, Martin AA, Hagstrom SA, Martin DF, Group CR (2014) Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Ophthalmology 121(1):150\u2013161. https:\/\/doi.org\/10.1016\/j.ophtha.2013.08.015","journal-title":"Ophthalmology"},{"issue":"2","key":"9717_CR6","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2(2):e106\u2013116. https:\/\/doi.org\/10.1016\/S2214-109X(13)70145-1","journal-title":"Lancet Glob Health"},{"issue":"11","key":"9717_CR7","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/nprot.2013.135","volume":"8","author":"V Lambert","year":"2013","unstructured":"Lambert V, Lecomte J, Hansen S, Blacher S, Gonzalez ML, Struman I, Sounni NE, Rozet E, de Tullio P, Foidart JM, Rakic JM, Noel A (2013) Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. Nat Protoc 8(11):2197\u20132211. https:\/\/doi.org\/10.1038\/nprot.2013.135","journal-title":"Nat Protoc"},{"key":"9717_CR8","first-page":"707","volume":"77","author":"SJ Ryan","year":"1979","unstructured":"Ryan SJ (1979) The development of an experimental model of subretinal neovascularization in disciform macular degeneration. Trans Am Ophthalmol Soc 77:707\u2013745","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"7","key":"9717_CR9","doi-asserted-by":"publisher","first-page":"e0132643","DOI":"10.1371\/journal.pone.0132643","volume":"10","author":"Y Gong","year":"2015","unstructured":"Gong Y, Li J, Sun Y, Fu Z, Liu CH, Evans L, Tian K, Saba N, Fredrick T, Morss P, Chen J, Smith LE (2015) Optimization of an image-guided laser-induced choroidal neovascularization model in mice. PLoS ONE 10(7):e0132643. https:\/\/doi.org\/10.1371\/journal.pone.0132643","journal-title":"PLoS ONE"},{"issue":"2","key":"9717_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/jcp.10246","volume":"195","author":"Y Saishin","year":"2003","unstructured":"Saishin Y, Saishin Y, Takahashi K, Lima e Silva R, Hylton D, Rudge JS, Wiegand SJ, Campochiaro PA (2003) VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier. J Cell Physiol 195(2):241\u2013248. https:\/\/doi.org\/10.1002\/jcp.10246","journal-title":"J Cell Physiol"},{"issue":"8","key":"9717_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.molmed.2007.06.005","volume":"13","author":"A Noel","year":"2007","unstructured":"Noel A, Jost M, Lambert V, Lecomte J, Rakic JM (2007) Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts. Trends Mol Med 13(8):345\u2013352. https:\/\/doi.org\/10.1016\/j.molmed.2007.06.005","journal-title":"Trends Mol Med"},{"issue":"10","key":"9717_CR12","doi-asserted-by":"publisher","first-page":"e10473","DOI":"10.15252\/emmm.201910473","volume":"11","author":"Z Fu","year":"2019","unstructured":"Fu Z, Chen CT, Cagnone G, Heckel E, Sun Y, Cakir B, Tomita Y, Huang S, Li Q, Britton W, Cho SS, Kern TS, Hellstrom A, Joyal JS, Smith LE (2019) Dyslipidemia in retinal metabolic disorders. EMBO Mol Med 11(10):e10473. https:\/\/doi.org\/10.15252\/emmm.201910473","journal-title":"EMBO Mol Med"},{"issue":"10","key":"9717_CR13","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s00417-007-0571-z","volume":"245","author":"T Yasukawa","year":"2007","unstructured":"Yasukawa T, Wiedemann P, Hoffmann S, Kacza J, Eichler W, Wang YS, Nishiwaki A, Seeger J, Ogura Y (2007) Glycoxidized particles mimic lipofuscin accumulation in aging eyes: a new age-related macular degeneration model in rabbits. Graefes Arch Clin Exp Ophthalmol 245(10):1475\u20131485. https:\/\/doi.org\/10.1007\/s00417-007-0571-z","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"9717_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1586\/eop.09.1","volume":"4","author":"T Yasukawa","year":"2009","unstructured":"Yasukawa T (2009) Inflammation in age related macular degeneration: pathological or physiological? Expert Rev Ophthalmol 4(2):107\u2013112","journal-title":"Expert Rev Ophthalmol"},{"issue":"7","key":"9717_CR15","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nm1591","volume":"13","author":"KM Connor","year":"2007","unstructured":"Connor KM, SanGiovanni JP, Lofqvist C, Aderman CM, Chen J, Higuchi A, Hong S, Pravda EA, Majchrzak S, Carper D, Hellstrom A, Kang JX, Chew EY, Salem N Jr, Serhan CN, Smith LEH (2007) Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 13(7):868\u2013873. https:\/\/doi.org\/10.1038\/nm1591","journal-title":"Nat Med"},{"issue":"4","key":"9717_CR16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nm.4059","volume":"22","author":"JS Joyal","year":"2016","unstructured":"Joyal JS, Sun Y, Gantner ML, Shao Z, Evans LP, Saba N, Fredrick T, Burnim S, Kim JS, Patel G, Juan AM, Hurst CG, Hatton CJ, Cui Z, Pierce KA, Bherer P, Aguilar E, Powner MB, Vevis K, Boisvert M, Fu Z, Levy E, Fruttiger M, Packard A, Rezende FA, Maranda B, Sapieha P, Chen J, Friedlander M, Clish CB, Smith LE (2016) Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1. Nat Med 22(4):439\u2013445. https:\/\/doi.org\/10.1038\/nm.4059","journal-title":"Nat Med"},{"key":"9717_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-nutr-071714-034410","volume":"35","author":"T Ulven","year":"2015","unstructured":"Ulven T, Christiansen E (2015) Dietary fatty acids and their potential for controlling metabolic diseases through activation of FFA4\/GPR120. Annu Rev Nutr 35:239\u2013263. https:\/\/doi.org\/10.1146\/annurev-nutr-071714-034410","journal-title":"Annu Rev Nutr"},{"issue":"1","key":"9717_CR18","doi-asserted-by":"publisher","first-page":"14318","DOI":"10.1038\/s41598-018-32553-5","volume":"8","author":"MN Datilo","year":"2018","unstructured":"Datilo MN, Sant'Ana MR, Formigari GP, Rodrigues PB, de Moura LP, da Silva ASR, Ropelle ER, Pauli JR, Cintra DE (2018) Omega-3 from flaxseed oil protects obese mice against diabetic retinopathy through GPR120 receptor. Sci Rep 8(1):14318. https:\/\/doi.org\/10.1038\/s41598-018-32553-5","journal-title":"Sci Rep"},{"issue":"7389","key":"9717_CR19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature10798","volume":"483","author":"A Ichimura","year":"2012","unstructured":"Ichimura A, Hirasawa A, Poulain-Godefroy O, Bonnefond A, Hara T, Yengo L, Kimura I, Leloire A, Liu N, Iida K, Choquet H, Besnard P, Lecoeur C, Vivequin S, Ayukawa K, Takeuchi M, Ozawa K, Tauber M, Maffeis C, Morandi A, Buzzetti R, Elliott P, Pouta A, Jarvelin MR, Korner A, Kiess W, Pigeyre M, Caiazzo R, Van Hul W, Van Gaal L, Horber F, Balkau B, Levy-Marchal C, Rouskas K, Kouvatsi A, Hebebrand J, Hinney A, Scherag A, Pattou F, Meyre D, Koshimizu TA, Wolowczuk I, Tsujimoto G, Froguel P (2012) Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 483(7389):350\u2013354. https:\/\/doi.org\/10.1038\/nature10798","journal-title":"Nature"},{"issue":"5","key":"9717_CR20","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","volume":"142","author":"DY Oh","year":"2010","unstructured":"Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM, Olefsky JM (2010) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142(5):687\u2013698. https:\/\/doi.org\/10.1016\/j.cell.2010.07.041","journal-title":"Cell"},{"issue":"6","key":"9717_CR21","doi-asserted-by":"publisher","first-page":"e40168","DOI":"10.1371\/journal.pone.0040168","volume":"7","author":"S Janssen","year":"2012","unstructured":"Janssen S, Laermans J, Iwakura H, Tack J, Depoortere I (2012) Sensing of fatty acids for octanoylation of ghrelin involves a gustatory G-protein. PLoS ONE 7(6):e40168. https:\/\/doi.org\/10.1371\/journal.pone.0040168","journal-title":"PLoS ONE"},{"issue":"8","key":"9717_CR22","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm.3614","volume":"20","author":"DY Oh","year":"2014","unstructured":"Oh DY, Walenta E, Akiyama TE, Lagakos WS, Lackey D, Pessentheiner AR, Sasik R, Hah N, Chi TJ, Cox JM, Powels MA, Di Salvo J, Sinz C, Watkins SM, Armando AM, Chung H, Evans RM, Quehenberger O, McNelis J, Bogner-Strauss JG, Olefsky JM (2014) A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice. Nat Med 20(8):942\u2013947. https:\/\/doi.org\/10.1038\/nm.3614","journal-title":"Nat Med"},{"issue":"10","key":"9717_CR23","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1167\/iovs.17-21796","volume":"58","author":"Z Fu","year":"2017","unstructured":"Fu Z, Liegl R, Wang Z, Gong Y, Liu CH, Sun Y, Cakir B, Burnim SB, Meng SS, Lofqvist C, SanGiovanni JP, Hellstrom A, Smith LEH (2017) Adiponectin mediates dietary omega-3 long-chain polyunsaturated fatty acid protection against choroidal neovascularization in mice. Invest Ophthalmol Vis Sci 58(10):3862\u20133870. https:\/\/doi.org\/10.1167\/iovs.17-21796","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9717_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exer.2012.06.003","volume":"102","author":"C Xin-Zhao Wang","year":"2012","unstructured":"Xin-Zhao Wang C, Zhang K, Aredo B, Lu H, Ufret-Vincenty RL (2012) Novel method for the rapid isolation of RPE cells specifically for RNA extraction and analysis. Exp Eye Res 102:1\u20139. https:\/\/doi.org\/10.1016\/j.exer.2012.06.003","journal-title":"Exp Eye Res"},{"issue":"7","key":"9717_CR25","doi-asserted-by":"publisher","first-page":"e69552","DOI":"10.1371\/journal.pone.0069552","volume":"8","author":"Z Shao","year":"2013","unstructured":"Shao Z, Friedlander M, Hurst CG, Cui Z, Pei DT, Evans LP, Juan AM, Tahiri H, Duhamel F, Chen J, Sapieha P, Chemtob S, Joyal JS, Smith LE (2013) Choroid sprouting assay: an ex vivo model of microvascular angiogenesis. PLoS ONE 8(7):e69552. https:\/\/doi.org\/10.1371\/journal.pone.0069552","journal-title":"PLoS ONE"},{"issue":"4","key":"9717_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000232946","volume":"42","author":"A Garcia-Layana","year":"2009","unstructured":"Garcia-Layana A, Vasquez G, Salinas-Alaman A, Moreno-Montanes J, Recalde S, Fernandez-Robredo P (2009) Development of laser-induced choroidal neovascularization in rats after retinal damage by sodium iodate injection. Ophthal Res 42(4):205\u2013212. https:\/\/doi.org\/10.1159\/000232946","journal-title":"Ophthal Res"},{"key":"9717_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2016.01.021","volume":"110\u2013111","author":"NH Moniri","year":"2016","unstructured":"Moniri NH (2016) Free-fatty acid receptor-4 (GPR120): Cellular and molecular function and its role in metabolic disorders. Biochem Pharmacol 110\u2013111:1\u201315. https:\/\/doi.org\/10.1016\/j.bcp.2016.01.021","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"9717_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.tips.2011.04.004","volume":"32","author":"S Talukdar","year":"2011","unstructured":"Talukdar S, Olefsky JM, Osborn O (2011) Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases. Trends Pharmacol Sci 32(9):543\u2013550. https:\/\/doi.org\/10.1016\/j.tips.2011.04.004","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"9717_CR29","doi-asserted-by":"publisher","first-page":"e97957","DOI":"10.1371\/journal.pone.0097957","volume":"9","author":"Y Williams-Bey","year":"2014","unstructured":"Williams-Bey Y, Boularan C, Vural A, Huang NN, Hwang IY, Shan-Shi C, Kehrl JH (2014) Omega-3 free fatty acids suppress macrophage inflammasome activation by inhibiting NF-kappaB activation and enhancing autophagy. PLoS ONE 9(6):e97957. https:\/\/doi.org\/10.1371\/journal.pone.0097957","journal-title":"PLoS ONE"},{"issue":"12","key":"9717_CR30","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.1096\/fj.13-235333","volume":"27","author":"X Li","year":"2013","unstructured":"Li X, Yu Y, Funk CD (2013) Cyclooxygenase-2 induction in macrophages is modulated by docosahexaenoic acid via interactions with free fatty acid receptor 4 (FFA4). FASEB J 27(12):4987\u20134997. https:\/\/doi.org\/10.1096\/fj.13-235333","journal-title":"FASEB J"},{"issue":"9","key":"9717_CR31","first-page":"1891","volume":"40","author":"H Oh","year":"1999","unstructured":"Oh H, Takagi H, Takagi C, Suzuma K, Otani A, Ishida K, Matsumura M, Ogura Y, Honda Y (1999) The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci 40(9):1891\u20131898","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"9717_CR32","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/j.ajpath.2011.01.013","volume":"178","author":"S Lavalette","year":"2011","unstructured":"Lavalette S, Raoul W, Houssier M, Camelo S, Levy O, Calippe B, Jonet L, Behar-Cohen F, Chemtob S, Guillonneau X, Combadiere C, Sennlaub F (2011) Interleukin-1beta inhibition prevents choroidal neovascularization and does not exacerbate photoreceptor degeneration. Am J Pathol 178(5):2416\u20132423. https:\/\/doi.org\/10.1016\/j.ajpath.2011.01.013","journal-title":"Am J Pathol"},{"issue":"4","key":"9717_CR33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/IAE.0b013e318195cb15","volume":"29","author":"MI Roh","year":"2009","unstructured":"Roh MI, Kim HS, Song JH, Lim JB, Koh HJ, Kwon OW (2009) Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with amd after bevacizumab treatment. Retina 29(4):523\u2013529. https:\/\/doi.org\/10.1097\/IAE.0b013e318195cb15","journal-title":"Retina"},{"key":"9717_CR34","first-page":"574","volume":"18","author":"H Miao","year":"2012","unstructured":"Miao H, Tao Y, Li XX (2012) Inflammatory cytokines in aqueous humor of patients with choroidal neovascularization. Mol Vis 18:574\u2013580","journal-title":"Mol Vis"},{"issue":"6","key":"9717_CR35","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.2353\/ajpath.2007.061018","volume":"170","author":"K Izumi-Nagai","year":"2007","unstructured":"Izumi-Nagai K, Nagai N, Ozawa Y, Mihara M, Ohsugi Y, Kurihara T, Koto T, Satofuka S, Inoue M, Tsubota K, Okano H, Oike Y, Ishida S (2007) Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization. Am J Pathol 170(6):2149\u20132158. https:\/\/doi.org\/10.2353\/ajpath.2007.061018","journal-title":"Am J Pathol"},{"key":"9717_CR36","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ebiom.2018.12.019","volume":"39","author":"J Huang","year":"2019","unstructured":"Huang J, Xue M, Zhang J, Yu H, Gu Y, Du M, Ye W, Wan B, Jin M, Zhang Y (2019) Protective role of GPR120 in the maintenance of pregnancy by promoting decidualization via regulation of glucose metabolism. EBioMedicine 39:540\u2013551. https:\/\/doi.org\/10.1016\/j.ebiom.2018.12.019","journal-title":"EBioMedicine"},{"key":"9717_CR37","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201708047","author":"M Schilperoort","year":"2018","unstructured":"Schilperoort M, van Dam AD, Hoeke G, Shabalina IG, Okolo A, Hanyaloglu AC, Dib LH, Mol IM, Caengprasath N, Chan YW, Damak S, Miller AR, Coskun T, Shimpukade B, Ulven T, Kooijman S, Rensen PC, Christian M (2018) The GPR120 agonist TUG-891 promotes metabolic health by stimulating mitochondrial respiration in brown fat. EMBO Mol Med. https:\/\/doi.org\/10.15252\/emmm.201708047","journal-title":"EMBO Mol Med"},{"issue":"9","key":"9717_CR38","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1248\/yakushi.19-00011-4","volume":"139","author":"K Nakamoto","year":"2019","unstructured":"Nakamoto K, Tokuyama S (2019) Involvement of the free fatty acid receptor GPR120\/FFAR4 in the development of nonalcoholic steatohepatitis. Yakugaku Zasshi 139(9):1169\u20131175. https:\/\/doi.org\/10.1248\/yakushi.19-00011-4","journal-title":"Yakugaku Zasshi"},{"issue":"2","key":"9717_CR39","doi-asserted-by":"publisher","first-page":"e88005","DOI":"10.1371\/journal.pone.0088005","volume":"9","author":"V Nobili","year":"2014","unstructured":"Nobili V, Carpino G, Alisi A, De Vito R, Franchitto A, Alpini G, Onori P, Gaudio E (2014) Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease. PLoS ONE 9(2):e88005. https:\/\/doi.org\/10.1371\/journal.pone.0088005","journal-title":"PLoS ONE"},{"issue":"3","key":"9717_CR40","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jhep.2013.11.006","volume":"60","author":"DA Raptis","year":"2014","unstructured":"Raptis DA, Limani P, Jang JH, Ungethum U, Tschuor C, Graf R, Humar B, Clavien PA (2014) GPR120 on Kupffer cells mediates hepatoprotective effects of omega3-fatty acids. J Hepatol 60(3):625\u2013632. https:\/\/doi.org\/10.1016\/j.jhep.2013.11.006","journal-title":"J Hepatol"},{"issue":"5","key":"9717_CR41","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1124\/mol.113.087783","volume":"84","author":"BD Hudson","year":"2013","unstructured":"Hudson BD, Shimpukade B, Mackenzie AE, Butcher AJ, Pediani JD, Christiansen E, Heathcote H, Tobin AB, Ulven T, Milligan G (2013) The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4\/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism. Mol Pharmacol 84(5):710\u2013725. https:\/\/doi.org\/10.1124\/mol.113.087783","journal-title":"Mol Pharmacol"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-020-09717-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10456-020-09717-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-020-09717-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T19:25:14Z","timestamp":1614885914000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10456-020-09717-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["9717"],"URL":"https:\/\/doi.org\/10.1007\/s10456-020-09717-x","relation":{},"ISSN":["0969-6970","1573-7209"],"issn-type":[{"value":"0969-6970","type":"print"},{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,5]]},"assertion":[{"value":"5 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no duality of interest associated with this manuscript. Saswata Talukdar is an employee and stockholder of Merck &Co.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal studies adhered to the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research and were approved by Institutional Animal Care and Use Committee at Boston Children\u2019s Hospital (ARCH Protocol Number 19-04-3913R).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}